Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
The central component of hypoxia sensing in the cell is the hypoxia-inducible factor (HIF) transcriptional complex. HIF activity is deregulated in many human cancers, especially those that are highly hypoxic. Hypoxic tumour cells are usually resistant to radiotherapy and most conventional chemothera...
Main Authors: | Poon, E, Harris, A, Ashcroft, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Genetic insights into the hypoxia-inducible factor (HIF) pathway.
by: Kiriakidis, S, et al.
Published: (2007) -
Activation of hypoxia-inducible factor (HIF) pathway in varicose veins
by: Lim, C, et al.
Published: (2011) -
Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.
by: Webb, J, et al.
Published: (2009) -
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
by: Reem A. Qannita, et al.
Published: (2024-02-01) -
Hypoxia and HIF pathway in cancer and the placenta
by: Macklin, P, et al.
Published: (2017)